Loading
journalsJournal
Oncotarget
Oncotarget is a large online cancer research journal that publishes on anything that can be viewed as a target relevant to cancer, from molecules and pathways to cell types. It is read by basic and translational cancer researchers.
Also called: Oncotarget
Overview
Oncotarget describes itself as a primarily oncology-focused, peer-reviewed, open access journal that aims to maximise research impact through insightful peer review, to eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences, and to foster the application of basic and clinical science. The term oncotarget, introduced in the inaugural editorial, covers all molecules, pathways, cellular functions, cell types and tissues that can be viewed as targets relevant to cancer and other diseases. The journal started in 2009 and is published from Albany, New York, by Impact Journals (Rapamycin Press LLC). Since 1 January 2022 it has used a continuous publishing model, releasing papers in final form within yearly volumes. The NLM Catalog quotes its self-description as an open access impact journal and lists it in MEDLINE and PubMed Central; it is not currently listed in the Directory of Open Access Journals.
Publisher
Impact Journals (Rapamycin Press LLC)
Scope
cancer research and oncology targets
Website
Founded
2009
ISSN
1949-2553
Ander Urruticoechea
Presidente (President) of GEICAM, the Spanish Breast Cancer Group
Medical oncologyBreast cancerAcademic clinical research
Medical oncologist from Gipuzkoa who became President of GEICAM, Spain's academic breast cancer research group, in 2025 on the retirement of its founder Miguel Martín.
Derrick S. Haslem
Senior Medical Director of the Oncology Clinical Program, Intermountain Health
Medical oncologyBreast cancerCancer genomics and targeted therapy
Medical oncologist who leads the oncology clinical programme across Intermountain Health's cancer centres in Utah and neighbouring states.
Jean-Philippe Spano
Representative of Institut Universitaire de Cancérologie AP-HP Sorbonne Université to the Organisation of European Cancer Institutes
Cancer centre representation (OECI)
Jean-Philippe Spano represents Institut Universitaire de Cancérologie AP-HP Sorbonne Université in the Organisation of European Cancer Institutes, which lists the centre among its members in France.
Jihui Hao
President, Tianjin Medical University Cancer Institute and Hospital
Surgical oncologyHospital managementCancer research
Physician-scientist who is President of Tianjin Medical University Cancer Institute and Hospital, one of China's largest specialist cancer hospitals and a National Clinical Research Center for Malignant Tumors.
Marek Svoboda
General Director
Medical oncologyBreast cancerCancer genetics
Medical oncologist who leads the Masaryk Memorial Cancer Institute in Brno, the Czech Republic's largest dedicated cancer centre.
Similar pages
- JournalRadiation oncology
Shares Marek Svoboda, PubMed & Europe PMC.